Company news

Solana Company news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results

May 16, 2021

Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st

April 14, 2021

Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

April 6, 2021

Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device

March 28, 2021

Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd

March 16, 2021

Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors

March 16, 2021

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

March 9, 2021

Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021

February 1, 2021

Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

January 31, 2021

Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market

January 27, 2021

Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices

January 19, 2021

Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards

January 18, 2021

Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference

January 14, 2021

Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis

January 10, 2021

Helius Medical Technologies, Inc. Comments on Unusual Market Activity

January 4, 2021

Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January

January 3, 2021

Helius Medical Technologies, Inc. Announces Reverse Stock Split

December 30, 2020

Helius Medical Technologies to Present at the virtual Fall Investor Summit on November 16th-18th

November 11, 2020

Helius Medical Technologies, Inc. Reports Third Quarter of Fiscal Year 2020 Financial Results

November 11, 2020

Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November

November 4, 2020

Helius Medical Technologies, Inc. Announces the Expansion to a Total of 27 Authorized PoNS Treatment™ Clinic Locations Across Canada

November 3, 2020

Helius Medical Technologies to Release Third Quarter of Fiscal Year 2020 Financial Results on November 12, 2020

November 1, 2020

Helius Medical Technologies Announces Closing of $3.4 Million Private Placement

October 25, 2020

Helius Medical Technologies Announces $3.4 Million Private Placement

October 20, 2020

Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis

October 18, 2020

Helius Medical Technologies, Inc. Announces Partnership with Breakthrough Health for Multiple Sclerosis Insights

October 13, 2020

Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory Board

October 7, 2020

Helius Medical Technologies, Inc. to Present at Three Upcoming Investor Conferences in September

August 30, 2020

Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results

August 11, 2020

Helius Medical Technologies to Release Second Quarter of Fiscal Year 2020 Financial Results on August 12, 2020

August 9, 2020

Helius Medical Technologies, Inc. Submits Request for FDA Clearance for PoNS™ Device; Reports Preliminary Financial Results for the Second Quarter and Six Months Ended June 30, 2020

August 5, 2020

Helius Medical Technologies Announces the Dismissal of the Shareholder Class Action Lawsuit

July 13, 2020

Helius Medical Technologies to Present at the Virtual Summer Summit on June 9th

June 4, 2020

Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis

May 11, 2020

Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook

May 6, 2020

Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBI

April 29, 2020

Helius Medical Technologies to Release First Quarter of Fiscal Year 2020 Financial Results on May 7, 2020

April 21, 2020

Helius Medical Technologies Appoints Jeffrey S. Mathiesen to its Board of Directors

April 21, 2020

Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS™ Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS)

March 23, 2020

Helius Medical Technologies Announces $2.2 Million Registered Direct Offering

March 17, 2020

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results; Introduces Full Year 2020 Outlook

March 11, 2020

Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment™ Clinics

March 8, 2020

Helius Medical Technologies CEO Philippe Deschamps to Deliver Congressional Briefing on the Latest Technologies, Innovations and Policies in Clinical Neuroscience

February 23, 2020

Helius Medical Technologies Inc. Welcomes Cline Medical Centre as an Authorized PoNS Treatment™ Clinic in Nanaimo, BC

February 6, 2020

Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 12, 2020

February 4, 2020

Helius Medical Technologies, Inc. Issues a Clarification to the News Release Regarding the Agreement with the University Health Network (UHN) Issued at 7: 05 am January 16, 2020

January 15, 2020

Helius Medical Technologies Awarded Pioneer Technology Development Award

January 9, 2020

Helius Medical Technologies, Inc. Announces Pricing of Public Offering

November 21, 2019

Helius Medical Technologies, Inc. Announces Proposed Public Offering

November 20, 2019

Helius Medical Technologies, Inc. Announces Addition of P3 Health As New Authorized PoNS Treatment™ Clinic in Toronto, Canada

November 18, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 15 calls. Every call is listed under its year.

Decks

The 5 newest of 17 decks. Every deck is listed under its year.